Drug Profile
Simvastatin controlled-release - Hanmi Pharmaceutical
Alternative Names: Simvast CRLatest Information Update: 14 Jan 2022
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Antihyperlipidaemics; Naphthalenes; Small molecules
- Mechanism of Action HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Hyperlipidaemia